Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
Inflammatory bowel disease (IBD) is an autoimmune disease that causes chronic intestinal inflammation. Intestinal microbiota is involved in the pathogenesis of IBD. In this study, we investigated the effects of periodontal bacterial species on IBD patients. We found that the amount of bacteria was higher in CD than in healthy controls. Fusobacterium nucleatum associated with periodontal disease was found to be more abundant in UC. Furthermore, Fusobacterium nucleatum was orally administered to mice. However, no direct effect on the mesenteric lymph nodes or intestine was observed. Fusobacterium nucleatum was also orally administered to a mouse model of dextran sulfate-induced colitis, however no direct effects on enteritis or inflammatory responses were observed.
|